Figures computed from official regulatory filings — .
Ownershipinsiders 48.6% · institutions 0.04% · short 4.7% of float
In USD · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for NYMOX PHARMACEUTICAL CORP only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of products for the aging population. Its lead drug candidate is Fexapotide Triflutate (NX-1207) for the treatment of benign prostatic hyperplasia and low-grade localized prostate cancer, as well as hepatocellular carcinoma. The company also offers NicAlert, a simple, cost-effective test for determining smoking status; and TobacAlert, a test for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment and prevention of Alzheimer's disease. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, Bahamas.
Market information source · Oct 19, 2026
SEC company identity · Oct 19, 2026
Open-market timeline · full history
381 buys2 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Robinson James Georgetrack record | Buy | $18K | conv 39 |
| Robinson James Georgetrack record | Buy | $18.8K | conv 21 | SEC |
| Robinson James Georgetrack record | Buy | $18K | conv 39 | SEC |
| Robinson James Georgetrack record | BuyD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | First in 12mo | SEC |
| Robinson James Georgetrack record | Buy | $1.9M | conv 73Unusual sizeFirst in 12mo | SEC |
| Robinson James Georgetrack record | Buy | $418 | conv 23 | SEC |
| Robinson James Georgetrack record | Buy | $12.5K | conv 37First in 12mo | SEC |
| Robinson James Georgetrack record | Buy | $4.2K | conv 37First in 12mo | SEC |
| Robinson James Georgetrack record | Buy | $14.5K | conv 41Unusual size | SEC |
| Robinson James Georgetrack record | Buy | $106.1 | conv 23 | SEC |
| Robinson James Georgetrack record | Buy | $2.3K | conv 23 | SEC |
| Robinson James Georgetrack record | Buy | $10.3K | conv 34 | SEC |
| Robinson James Georgetrack record | Buy | $8.5K | conv 37First in 12mo | SEC |
| Robinson James Georgetrack record | Buy | $1.7K | conv 23 | SEC |
| Robinson James Georgetrack record | Buy | $1.9K | conv 37First in 12mo | SEC |
| Robinson James Georgetrack record | Buy | $6.5K | conv 27 | SEC |
| Robinson James Georgetrack record | Buy | $4K | conv 23 | SEC |
| Robinson James Georgetrack record | Buy | $10.3K | conv 34 | SEC |
| Robinson James Georgetrack record | Buy | $6.1K | conv 26 | SEC |
| Robinson James Georgetrack record | Buy | $287.2 | conv 23 | SEC |
| Robinson James Georgetrack record | Buy | $10.1K | conv 23 | SEC |
| Robinson James Georgetrack record | Buy | $1K | conv 23 | SEC |
| Robinson James Georgetrack record | Buy | $172 | conv 23 | SEC |
| Robinson James Georgetrack record | Buy | $519 | conv 23 | SEC |
| Robinson James Georgetrack record | Buy | $11.4K | conv 24 | SEC |